
No transactions found.
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenues | $13.1M-6.0% | $13.9M+13.3% | $12.3M+9.7% | $11.2M+15.7% | $9.7M |
| Cost of product | $5.4M+2.2% | $5.3M+7.4% | $4.9M-0.1% | $4.9M+24.7% | $3.9M |
| Gross profit | $7.7M-10.9% | $8.6M+17.2% | $7.4M+17.3% | $6.3M+9.6% | $5.7M |
| Salaries and contract labor | $4.5M+11.6% | $4.0M-0.3% | $4.0M+18.9% | $3.4M+26.2% | $2.7M |
| General, administrative, and consulting | $3.7M-6.9% | $4.0M+13.1% | $3.5M-0.6% | $3.6M+3.2% | $3.5M |
| Research and development | $436K-28.6% | $611K+5.8% | $577K+8.2% | $534K+96.4% | $272K |
| Total operating expenses | $8.7M+0.2% | $8.6M+6.0% | $8.2M+8.8% | $7.5M+16.7% | $6.4M |
| Operating profit (loss) | -$956K-13955.8% | $7K+100.9% | -$776K+35.5% | -$1.2M-76.7% | -$681K |
| Other income | $311K+49.5% | $208K+29.8% | $160K-92.4% | $2.1M+208.9% | $683K |
| Interest income | $77K-37.4% | $122K+55.1% | $79K+730.2% | $10K+8460.4% | $111 |
| Interest expense | -$339K-3.2% | -$329K+0.9% | -$332K+46.0% | -$614K+22.4% | -$792K |
| Total other (expense) income | $48K+2780.2% | $2K+101.8% | -$93K-106.2% | $1.5M+1492.4% | -$108K |
| Net income (loss) | -$908K-10690.2% | $9K+101.0% | -$869K-386.6% | $303K+138.4% | -$789K |
| Net income (loss) per common share - basic: (in dollars per share) | $0 | $0 | $0 | $0 | — |
| Net income (loss) per common share - diluted: (in dollars per share) | $0 | $0 | $0 | $0 | — |
| Weighted average common shares outstanding - basic (in shares) | $526.8M+0.9% | $522.3M+0.9% | $517.8M+1.4% | $510.8M+6.9% | $477.7M |
| Weighted average common shares outstanding - diluted (in shares) | $526.8M+0.9% | $522.3M+0.9% | $517.8M+1.4% | $510.8M+6.9% | $477.7M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Radnostix, Inc. Reports FY2026 Q1 Results - Revenue Declines 27% Primarily Due to Voluntary Product Recalls, Isotope Supply Disruptions, and Planned Operational Shutdown
Radnostix, Inc. Reports FY2025 Results - Second-Highest Annual Revenue in Company History; Delivers Strong Growth in Calibration & Reference Products and Advances Key Product Launches in 2025
Mutual Termination of the Asset Purchase Agreement related to the Radnostix DUF6 Assets
International Isotopes Inc. Announces Company Name Change to Radnostix, Inc.